Search Results 601-610 of 18317 for peptides

  1. Use of simultaneous liver transplant and sleeve gastrectomy in managing patients with obesity and end-stage liver disease - Mayo Clinic

    ... peptide-1 (GLP-1) agonists and other medical treatments. For more information. Larson EL, et al. Simultaneous liver transplant and sleeve gastrectomy ...

  2. Endocrinology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  3. Type 2 diabetes - Symptoms and causes - Mayo Clinic

    Over time, high blood sugar levels in type 2 diabetes can damage the eyes, kidneys, nerves and heart. This can happen because the pancreas doesn't make enough ...

  4. Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) - Mayo Clinic

    Known history of allergy to TNFα, anthracyclines or other intravenously administered human proteins/peptides/antibodies. Absolute neutrophil count (ANC) ...

  5. Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet - Mayo Clinic

    ... peptide (DGP) \<3 × ULN. Note: Participants may be retested for IgA tTG and IgG DGP to meet eligibility criteria at the discretion of the investigator ...

  6. A Study to Evaluate Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery - Mayo Clinic

    Active treatment with any insulin/insulin secretagogues, or other diabetes medications except for acarbose and glucagon-like peptide 1 (GLP-1) analogues.

  7. Dr. Andres Acosta Archives - Mayo Clinic News Network

    ... peptide-1 (GLP-1). Semaglutide medications such as Wegovy, Ozempic and Rybelsus work on behalf of the GLP-1 hormone. They connect between the gut and the ...

  8. Mike G. Kattah, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Mike G. Kattah, M.D., Ph.D., studies inflammatory bowel disease such as ulcerative colitis and Crohn's disease, as well as immune ...

  9. Publications - Joseph Y. Cheung, M.D. - Mayo Clinic

    Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed ...

  10. Short Bowel Syndrome Clinical Trials - Mayo Clinic Research

    Investigator plans to examine the gastrointestinal (GI) physiologic profile of Teduglutide, a Glucagon-like Peptide 2 Analog as a possible intestinotrophic ...